source
- STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and morePresident Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White HouseSTAT · 3mo ago↗ source
- STAT+: Sanofi MS drug gets positive review in Europe following FDAA multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.STAT · 3mo ago↗ source
- Opinion: I started medical school at 69 and will begin residency at 72. Here’s what I learnedStarting residency at 72 isn’t for the faint of heart. But that’s what Dawn Zuidegeest-Craft is doing.STAT · 3mo ago↗ source